View All Documents

Past Conference Resources

TitleCategorieshf:doc_categories
Evidence-Based Recommendations for the Use of Machine Perfusion in Kidney TransplantationHOPE in Other Organshope-in-other-organs
Machine perfusion modulates cold-preservation injury in kidney transplantation: IDEAL stage 4 United States population cohort studyHOPE in Other Organshope-in-other-organs
Propensity Score-matched Real-world Data: HCC Recurrence Rates After DBD Liver Transplantation in Times of Machine PerfusionTumor Recurrencetumor-recurrence
Pushing the Limit for Marginal Grafts in the Era of Machine Perfusion: A Tale of HOPE From a Leading Italian InstitutionLiver Clinicalliver-clinical
Impact of HOPE on Very Old DCD (>70 Years) Livers: Insights From A Belgian Bi-centeric ExperienceLiver Clinicalliver-clinical
Beneficial Effects of End?Ischemic Oxygenated Machine Perfusion Preservation for Split?Liver Transplantation in Recovering Graft Function and Reducing Ischemia–Reperfusion InjuryLiver Clinicalliver-clinical
HOPE Presentation – IntestinesHOPE in Other Organshope-in-other-organs
HOPE Presentation – Kidney & PancreasHOPE in Other Organshope-in-other-organs
Economic Assessment Of Hypothermic Oxygenated Machine Perfusion In Liver Transplantation: Interim Analysis, D. Axelrod, University of Iowa, Iowa City, IA et al.Bridge to HOPEbridge-to-hope
Success Of Ex Situ End Ischemic Hypothermic Oxygenated Perfusion (hope) Prior To Liver Transplantation – The Bridge To Hope Pivotal Multicenter Randomized Controlled Clinical Trial On The Safety And Effectiveness Of The VitaSmart Liver Machine Perfusion SystemBridge to HOPEbridge-to-hope
Decreased Ischemic Cholangiopathy With Hypothermic Oxygenated Perfusion: Sub Analysis Of Biliary Outcomes From The Us Pivotal Multicenter Trial Of The Vitasmart For Hope In Liver TransplantationBridge to HOPEbridge-to-hope
Hydroxyethyl Starch–Based Preservation Solutions Enhance Gene Therapy Vector Delivery Under Hypothermic ConditionsPreservation Solutionspreservation-solutions
Preservation Solutions for Kidney Transplantation: History, Advances and MechanismsPreservation Solutionspreservation-solutions
UW Solution: Still the “Gold Standard” for Liver TransplantationPreservation Solutionspreservation-solutions
Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival of Deceased Donor Kidney TransplantsPreservation Solutionspreservation-solutions
Histidine–Tryptophan–Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Deceased Donor Livers, Especially Those Donated After Cardiac DeathPreservation Solutionspreservation-solutions
Histidine-Tryptophan-Ketoglutarate (HTK) Is Associated with Reduced Graft Survival in Pancreas TransplantationPreservation Solutionspreservation-solutions
Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long-Term Graft Outcome Study From the European Liver Transplant RegistryPreservation Solutionspreservation-solutions
Abdominal Organ Preservation Solutions in the Age of Machine PerfusionPreservation Solutionspreservation-solutions
HOPE Mitigates Ischemia-Reperfusion Injury in Ex-Situ Split Grafts: A Comparative Study with Living Donation in Pediatric Liver TransplantationPediatricpediatric
The Role of Machine Perfusion for Liver Transplantation in ChildrenPediatricpediatric
Efficiency of Machine Perfusion in Pediatric Liver TransplantationPediatricpediatric
First UK HOPE Master ClassHOPE Lectures & Masterclasseshope-lectures-masterclasses
HOPE Iberia ConferenceHOPE Lectures & Masterclasseshope-lectures-masterclasses
Early Allograft Dysfunction As A Clinical Trial Primary Outcome Measure Correlates With Later Outcomes; Analysis From A US Pivotal Multicenter Medical Device Trial Of Hypothermic Oxygenated Perfusion For Liver TransplantBridge to HOPEbridge-to-hope
Economic Benefit of Hypothermic Liver PerfusionBridge to HOPEbridge-to-hope
Knowledge Hub Presentation on May 2 3:10 pm – 3:40 pm in Exhibition Area: Treatment and Assessment of Liver Grafts during HOPE presented by Phillip Dutkowski, University Hospital Basel, SwiterzlandMechanism of Actionmechanism-of-action
Hypothermic oxygenated machine perfusion is not associated with an increased risk of infection in the recipient: A retrospective single-centre cohort studyLiver Clinicalliver-clinical
Circulating cell-free DNA in liver transplantation: A pre- and post-transplant biomarker of graft dysfunctionLiver Clinicalliver-clinical
Outcomes of redo-liver transplantation using hypothermic oxygenated machine perfusion: A multicentre cohort study (REDO-HOPE),Liver Clinicalliver-clinical
Machine perfusion, an ace up your sleeve: unlocking liver graft potential from donation after circulatory death and previously rejected extended criteria donorsLiver Clinicalliver-clinical
Single center evolution of DCD donor utilization for liver transplantation: from perceived marginality to routine and beyondLiver Clinicalliver-clinical
Impact of hypothermic organ perfusion in small grafts in living donor liver transplantation to avoid small-for-size syndrome: safety & feasibility pilot study- phase-I HOPE-L trialLiver Clinicalliver-clinical
Hypothermic oxygenated perfusion (HOPE): Results of our experience in the first 31 liver transplantsLiver Clinicalliver-clinical
Results of the First 100 Cases of Hypothermic Oxygenated Perfusion in Liver Transplantation in a Portuguese Liver Transplant CenterLiver Clinicalliver-clinical
Quantifying Flavin mononucleotide: an internationally validated methodological approach for enhanced decision making in organ transplantationViability Assessmentviability-assessment
Screening for Mitochondrial Function Before Use-Routine Liver Assessment During Hypothermic Oxygenated Perfusion Impacts Liver UtilizationViability Assessmentviability-assessment
Assessment of liver graft quality during hypothermic oxygenated perfusion: the first international validation studyViability Assessmentviability-assessment
Flavin Mononucleotide as a Biomarker of Organ Quality-A Pilot StudyViability Assessmentviability-assessment
Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantationViability Assessmentviability-assessment
Viability Assessment in Liver Transplantation-What Is the Impact of Dynamic Organ Preservation?Viability Assessmentviability-assessment
Machine Perfusion as “Comfort Zone”: What Are Key Challenges of Liver Viability Assessment Today?Viability Assessmentviability-assessment
Preventing Tumour Recurrence after Liver Transplantation: The Role of Machine PerfusionTumor Recurrencetumor-recurrence
Mitochondria and Cancer Recurrence after Liver Transplantation-What Is the Benefit of Machine Perfusion?Tumor Recurrencetumor-recurrence
Hypothermic, oxygenated perfusion (HOPE) provides cardioprotection via succinate oxidation prior to normothermic perfusion in a rat model of donation after circulatory death (DCD)HOPE in Other Organshope-in-other-organs
Hypothermic oxygenated perfusion protects from mitochondrial injury before liver transplantationMechanism of Actionmechanism-of-action
Hypothermic Oxygenated Machine Perfusion (HOPE) Prior to Liver Transplantation Mitigates Post-Reperfusion Syndrome and Perioperative Electrolyte ShiftsMechanism of Actionmechanism-of-action
Extended hypothermic oxygenated machine perfusion enables ex situ preservation of porcine livers for up to 24 hoursLiver Clinicalliver-clinical
Beneficial effects of end-ischemic oxygenated machine perfusion preservation for split-liver transplantation in recovering graft function and reducing ischemia–reperfusion injury
Endothelial Cells and Mitochondria: Two Key Players in Liver Transplantation.Mechanism of Actionmechanism-of-action
Ischemia-Reperfusion Injury in Marginal Liver Grafts and the Role of Hypothermic Machine Perfusion: Molecular Mechanisms and Clinical ImplicationsMechanism of Actionmechanism-of-action
Impact of Machine Perfusion on the Immune Response After Liver Transplantation – A Primary Treatment or Just a Delivery ToolMechanism of Actionmechanism-of-action
Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study).Liver Clinicalliver-clinical
Normothermic Regional Perfusion and Hypothermic Oxygenated Machine Perfusion for Livers Donated After Controlled Circulatory Death With Prolonged Warm Ischemia Time: A Matched Comparison With Livers From Brain-Dead DonorsLiver Clinicalliver-clinical
Improved outcomes after hypothermic oxygenated machine perfusion in liver transplantation-Long-term follow-up of a multicenter randomized controlled trialLiver Clinicalliver-clinical
Hypothermic Machine Perfusion in Liver Transplantation – A Randomized TrialLiver Clinicalliver-clinical
Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death: Results From a Multicenter Randomized Controlled Trial (HOPE ECD-DBD)Liver Clinicalliver-clinical
Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathyLiver Clinicalliver-clinical
Prolonged preservation by hypothermic machine perfusion facilitates logistics in liver transplantation: A European observational cohort studyLiver Clinicalliver-clinical
Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-A randomized clinical trialLiver Clinicalliver-clinical
Liver Transplantation of Partial Grafts After Ex-Situ Splitting During Hypothermic Oxygenated Perfusion – The HOPE-Split Pilot StudyLiver Clinicalliver-clinical
Utilization of livers donated after circulatory death for transplantation – An international comparisonLiver Clinicalliver-clinical
A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantationLiver Clinicalliver-clinical
Machine perfusion techniques for liver transplantation- A meta-analysis of the first seven randomized-controlled trialsLiver Clinicalliver-clinical
Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search